Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04849728
Brief Title: A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)

First Submitted : April 16, 2021
First Submitted that Met QC Criteria : April 16, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : August 9, 2021
Last Update Posted : August 16, 2021